This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective

Highly Accessed Review

Does route of administration affect the outcome of TNF antagonist therapy?

Sergio Schwartzman* and G James Morgan

Arthritis Res Ther 2004, 6(Suppl 2):S19-S23 doi:10.1186/ar996

Accesses  

  • Last 30 days: 197 accesses
  • Last 365 days: 1740 accesses
  • All time: 11003 accesses

Cited by

BioMed Central: 1 citation

Google Scholar: View citations

PubMed Central: View citations